Definium Therapeutics Inc. Common Shares vs Equinox Gold Corp. Common Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Equinox Gold Corp. Common Shares trades at $11.4 (market cap $12.80B). The key difference: Equinox Gold Corp. Common Shares is far larger — about 2.7× Definium Therapeutics Inc. Common Shares's market cap, and Equinox Gold Corp. Common Shares pays a 0.48% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Equinox Gold Corp. Common Shares for 0 Days on average.
| DFTX | EQX | |
|---|---|---|
Market Cap | $4.71B | $12.80B |
Volume | 1,966,636 | 8,210,537 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $18.76 |
52-Week Low | $10.68 | $8.62 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $12.90B |
Dividend Yield | — | 0.48% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Equinox Gold is a gold mining company with operations in the Americas. It produces gold and develops additional mining projects.
Read more on EQX →